All News about Natera Inc
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
February 05, 2024
Via Benzinga
Topics
Bankruptcy
New Study Validates Signatera™ in Endometrial Cancer
February 05, 2024
From Natera, Inc.
Via Business Wire
Expert Ratings For Natera
January 17, 2024
Via Benzinga
Natera Inc. (NASDAQ: NTRA) Records 52-Week High Tuesday Morning
January 09, 2024
The Analyst Landscape: 8 Takes On Natera
December 29, 2023
Via Benzinga
The Latest Analyst Ratings for Natera
December 12, 2023
Via Benzinga
From FN Media Group LLC
Via GlobeNewswire
Natera Acquires Reproductive Health Assets from Invitae
January 22, 2024
From Natera, Inc.
Via Business Wire
Progress Software Posts Strong Q4 Results, Joins Impinj, REGENXBIO And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
January 17, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Bull of the Day - NeoGenomics
January 12, 2024
Via Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
From Natera, Inc.
Via Business Wire
From Natera, Inc.
Via Business Wire
From Natera, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.